Clinical outcomes with neoadjuvant versus adjuvant chemotherapy for triple negative breast cancer: A report from the National Cancer Database

Authors

Nusayba A Bagegni, Washington University School of Medicine in St. Louis
Yu Tao, Washington University School of Medicine in St. Louis
Foluso O Ademuyiwa, Washington University School of Medicine in St. Louis

Journal

PLoS One

Publication Date

2019

Volume

14

Issue

9

First Page

0222358

Document Type

Open Access Publication

DOI

10.1371/journal.pone.0222358

Rights and Permissions

Bagegni NA, Tao Y, Ademuyiwa FO (2019) Clinical outcomes with neoadjuvant versus adjuvant chemotherapy for triple negative breast cancer: A report from the National Cancer Database. PLOS ONE 14(9): e0222358. https://doi.org/10.1371/journal.pone.0222358

Recommended Citation

Bagegni, Nusayba A; Tao, Yu; and Ademuyiwa, Foluso O, "Clinical outcomes with neoadjuvant versus adjuvant chemotherapy for triple negative breast cancer: A report from the National Cancer Database." PLoS One. 14, 9. 0222358 (2019).
https://digitalcommons.wustl.edu/open_access_pubs/8370